Dsam Partners Llp Cut Kite Pharma (KITE) Holding By $5.67 Million, Last Week Biocept (BIOC) Coverage

June 20, 2017 - By Hazel Jackson

Among 3 analysts covering Biocept Inc (NASDAQ:BIOC), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Biocept Inc had 3 analyst reports since August 19, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, August 19 by H.C. Wainwright. The firm has “Buy” rating by Roth Capital given on Monday, June 6. See Biocept Inc (NASDAQ:BIOC) latest ratings:

02/06/2017 Broker: Chardan Capital Markets Rating: Buy New Target: $2.5 Initiates Coverage On

Dsam Partners Llp decreased Kite Pharma Inc (KITE) stake by 59% reported in 2016Q4 SEC filing. Dsam Partners Llp sold 128,810 shares as Kite Pharma Inc (KITE)’s stock rose 29.36%. The Dsam Partners Llp holds 89,502 shares with $4.01 million value, down from 218,312 last quarter. Kite Pharma Inc now has $5.36B valuation. The stock rose 4.50% or $4.02 reaching $93.31. About 755,446 shares traded. Kite Pharma Inc (NASDAQ:KITE) has risen 55.47% since June 20, 2016 and is uptrending. It has outperformed by 38.77% the S&P500.

Investors sentiment decreased to 1.31 in Q4 2016. Its down 0.32, from 1.63 in 2016Q3. It turned negative, as 34 investors sold KITE shares while 43 reduced holdings. 30 funds opened positions while 71 raised stakes. 43.05 million shares or 17.06% more from 36.77 million shares in 2016Q3 were reported. New York State Common Retirement Fund invested in 43,949 shares. Pictet Asset Mngmt Limited stated it has 287,370 shares. The Ontario – Canada-based Royal Bankshares Of Canada has invested 0.02% in Kite Pharma Inc (NASDAQ:KITE). Gp One Trading Limited Partnership reported 0.01% of its portfolio in Kite Pharma Inc (NASDAQ:KITE). Cg Asset Mgmt Ltd Liability Corporation holds 21,625 shares. Sg Americas Ltd Llc holds 0.01% or 32,413 shares in its portfolio. Moreover, Allianz Asset Management Ag has 0% invested in Kite Pharma Inc (NASDAQ:KITE). Menora Mivtachim Limited has 1.26 million shares for 2.9% of their portfolio. Pinnacle Assoc Limited holds 0.14% in Kite Pharma Inc (NASDAQ:KITE) or 157,990 shares. Waddell And Reed has invested 0.07% of its portfolio in Kite Pharma Inc (NASDAQ:KITE). Tower Rech Cap Limited Liability Corporation (Trc) has invested 0.02% of its portfolio in Kite Pharma Inc (NASDAQ:KITE). Tocqueville Asset Ltd Partnership invested 0.03% in Kite Pharma Inc (NASDAQ:KITE). Guggenheim Capital Ltd holds 0.01% of its portfolio in Kite Pharma Inc (NASDAQ:KITE) for 60,720 shares. Federated Inc Pa owns 0% invested in Kite Pharma Inc (NASDAQ:KITE) for 10,000 shares. Airain reported 0.03% of its portfolio in Kite Pharma Inc (NASDAQ:KITE).

Among 16 analysts covering Kite Pharma (NASDAQ:KITE), 11 have Buy rating, 1 Sell and 4 Hold. Therefore 69% are positive. Kite Pharma had 35 analyst reports since August 4, 2015 according to SRatingsIntel. Goldman Sachs initiated the stock with “Buy” rating in Wednesday, November 18 report. The stock of Kite Pharma Inc (NASDAQ:KITE) earned “Buy” rating by H.C. Wainwright on Monday, November 21. On Sunday, August 16 the stock rating was maintained by Stifel Nicolaus with “Buy”. Barclays Capital maintained the shares of KITE in report on Tuesday, August 9 with “Equal-Weight” rating. As per Wednesday, February 22, the company rating was initiated by Wells Fargo. As per Tuesday, January 19, the company rating was upgraded by FBR Capital. The firm has “Outperform” rating given on Monday, August 17 by Mizuho. The rating was initiated by Roth Capital on Wednesday, January 4 with “Buy”. The rating was maintained by FBR Capital on Friday, November 13 with “Mkt Perform”. The stock of Kite Pharma Inc (NASDAQ:KITE) earned “Buy” rating by FBR Capital on Friday, May 26.

Since January 6, 2017, it had 5 insider buys, and 21 sales for $21.79 million activity. Shares for $196,320 were sold by Kim Helen Susan. On Tuesday, May 9 Nussbaum Ran bought $679,474 worth of Kite Pharma Inc (NASDAQ:KITE) or 9,832 shares. $501,289 worth of Kite Pharma Inc (NASDAQ:KITE) shares were sold by BUTITTA CYNTHIA M. $3.45M worth of Kite Pharma Inc (NASDAQ:KITE) shares were bought by BONDERMAN DAVID. DOUMANI ROY sold 15,000 shares worth $1.27M. On Monday, May 1 the insider Chang David D sold $1.64 million. Shares for $250,427 were bought by JENKINSON PAUL L on Wednesday, May 10.

Dsam Partners Llp increased Baidu Inc (NASDAQ:BIDU) stake by 4,941 shares to 14,562 valued at $2.39M in 2016Q4. It also upped Activision Blizzard Inc (NASDAQ:ATVI) stake by 236,551 shares and now owns 536,551 shares. Trinseo S A (NYSE:TSE) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: